APA

Heymans S., Pauschinger M., De Palma A., Kallwellis-Opara A., Rutschow S., Swinnen M., Vanhoutte D., Gao F., Torpai R., Baker A. H., Padalko E., Neyts J., Schultheiss H., Van de Werf F., Carmeliet P. & Pinto Y. M. (20060822). Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. : Circulation.

Chicago

Heymans Stephane, Pauschinger Matthias, De Palma Armando, Kallwellis-Opara Angela, Rutschow Susanne, Swinnen Melissa, Vanhoutte Davy, Gao Fangye, Torpai Raimund, Baker Andrew H, Padalko Elisabeth, Neyts Johan, Schultheiss Heinz-Peter, Van de Werf Frans, Carmeliet Peter and Pinto Yigal M. 20060822. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. : Circulation.

Harvard

Heymans S., Pauschinger M., De Palma A., Kallwellis-Opara A., Rutschow S., Swinnen M., Vanhoutte D., Gao F., Torpai R., Baker A. H., Padalko E., Neyts J., Schultheiss H., Van de Werf F., Carmeliet P. and Pinto Y. M. (20060822). Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. : Circulation.

MLA

Heymans Stephane, Pauschinger Matthias, De Palma Armando, Kallwellis-Opara Angela, Rutschow Susanne, Swinnen Melissa, Vanhoutte Davy, Gao Fangye, Torpai Raimund, Baker Andrew H, Padalko Elisabeth, Neyts Johan, Schultheiss Heinz-Peter, Van de Werf Frans, Carmeliet Peter and Pinto Yigal M. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. : Circulation. 20060822.